The U.S. Government Accountability Office (GAO) and the U.S. Department of Health and Human Services, Office of Inspector General (OIG) both released reports confirming that PBM-negotiated rebates lower prescription drug costs in Medicare Part D.
Pharmaceutical Care
Management Association
505 9th Street NW, 10th Floor, Washington, DC 20004
© 2026 PCMA. All Rights Reserved.